logo

FENC

Fennec Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

FENC fundamentals

Fennec Pharmaceuticals (FENC) released its earnings on Nov 13, 2025: revenue was 12.50M (YoY +79.34%), beat estimates; EPS was -0.02 (YoY +90.48%), beat estimates.
Revenue / YoY
12.50M
+79.34%
EPS / YoY
-0.02
+90.48%
Report date
Nov 13, 2025
EPS
Revenue

Revenue & Expenses

FENC has released its 2025 Q3 earnings report, with revenue of 12.46M, reflecting a YoY change of 78.69%, and net profit of -638.00K, showing a YoY change of 88.88%. The Sankey diagram below clearly presents FENC's revenue sources and cost distribution.

Key Indicators

Fennec Pharmaceuticals (FENC) key financial stats and ratios, covering profitability, financial health, and leverage.
Fennec Pharmaceuticals (FENC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Fennec Pharmaceuticals (FENC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Fennec Pharmaceuticals (FENC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Fennec Pharmaceuticals (FENC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Fennec Pharmaceuticals (FENC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield